Amprius Technologies, Inc. (AMPX-WT)
Income Statement
Consolidated Statement of Income
AMPRIUS TECHNOLOGIES, INC. (AMPX.W)
Three Months Ended (In thousands, except shares in actual amounts and per share data)
| Mar 31, 2026 (Q1) | Mar 31, 2025 (Q1) | |
|---|---|---|
| Revenue | $28,536 | $11,284 |
| Cost of revenue | $22,796 | $13,645 |
| Gross profit (loss) | $5,740 | $(2,361) |
| Research and development | $3,799 | $2,003 |
| Selling, general and administrative | $8,628 | $5,307 |
| Total operating expenses | $12,427 | $7,310 |
| Loss from operations | (6,687) | (9,671) |
| Other income, net | $1,641 | $300 |
| Net loss | $(5,046) | $(9,371) |
| Weighted-average common shares outstanding, basic (in shares) | 136,947,076 | 117,969,812 |
| Weighted-average common shares outstanding, diluted (in shares) | 136,947,076 | 117,969,812 |
| Net loss per share of common stock, basic (in dollars per share) | -0.04 | -0.08 |
| Net loss per share of common stock, diluted (in dollars per share) | -0.04 | -0.08 |
Balance Sheet
Consolidated Balance Sheets
AMPRIUS TECHNOLOGIES, INC. (AMPX.W)
As of March 31, 2026 and December 31, 2025 (In thousands, except shares and per share data)
| Mar 31, 2026 | Dec 31, 2025 | |
|---|---|---|
| Cash and cash equivalents | $62,352 | $90,465 |
| Accounts receivable, net | $35,261 | $23,737 |
| Inventories | $8,246 | $6,735 |
| Prepaid expenses and other current assets | $8,095 | $5,500 |
| Total current assets | $113,954 | $126,437 |
| Property, plant and equipment, net | $10,746 | $9,680 |
| Operating lease right-of-use assets, net | $6,022 | $19,518 |
| Other assets | $62 | $1,256 |
| Total assets | $130,784 | $156,891 |
| Accounts payable | $8,882 | $6,700 |
| Accrued and other current liabilities | $3,170 | $3,666 |
| Deferred grant | $2,738 | $2,738 |
| Deferred revenue | $18 | $100 |
| Operating lease liabilities | $1,173 | $4,665 |
| Total current liabilities | $15,981 | $17,869 |
| Operating lease liabilities | $5,389 | $35,207 |
| Total liabilities | $21,370 | $53,076 |
| Commitments and contingencies (Note 10) | ||
| Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding | ||
| Common stock; $0.0001 par value; 950,000,000 shares authorized; 139,284,061 and 134,536,592 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | $13 | $13 |
| Additional paid-in capital | $332,795 | $322,156 |
| Accumulated other comprehensive income | $10 | $4 |
| Accumulated deficit | $(223,404) | $(218,358) |
| Total stockholders’ equity | $109,414 | $103,815 |
| Total liabilities and stockholders’ equity | $130,784 | $156,891 |
Cash Flow
Consolidated Statement of Cash Flows
AMPRIUS TECHNOLOGIES, INC. (AMPX.W)
Three Months Ended (In thousands, except shares and per share data)
| Mar 31, 2026 (Q1) | Mar 31, 2025 (Q1) | |
|---|---|---|
| Net loss | $(5,046) | $(9,371) |
| Stock-based compensation | $2,058 | $1,822 |
| Depreciation and amortization | $761 | $943 |
| Loss on termination of lease | $166 | |
| Write-down of property, plant and equipment | $77 | |
| Non-cash operating lease expense | $619 | $1,286 |
| Gain on disposal of property, plant and equipment | $(355) | |
| Other non-cash items | $(22) | $275 |
| Accounts receivable, net | $(11,489) | $(5,092) |
| Inventories | $(1,511) | $2,571 |
| Prepaid expenses and other current assets | $(2,621) | $(1,653) |
| Other assets | $13 | $10 |
| Accounts payable | $1,649 | $(1,697) |
| Accrued and other current liabilities | $(898) | $(2,512) |
| Deferred revenue | $(82) | $140 |
| Operating lease liabilities | $(20,594) | $(848) |
| Net cash used in operating activities | $(37,275) | $(14,126) |
| Purchase of property, plant and equipment | $(980) | $(913) |
| Proceeds from the disposal of property, plant and equipment | $355 | |
| Net cash used in investing activities | $(625) | $(913) |
| Proceeds from issuance of common stock in connection with the At Market Issuance Sales Agreement, net | $8,457 | |
| At Market Issuance Sales Agreement | $8,457 | |
| Proceeds from exercise of warrants | $1,895 | |
| Proceeds from exercise of stock options | $6,686 | $48 |
| Net cash provided by financing activities | $8,581 | $8,505 |
| Net decrease in cash, cash equivalents and restricted cash equivalents | $(29,319) | $(6,534) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | $6 | $(4) |
| Total cash, cash equivalents and restricted cash equivalents | ||
| Total cash, cash equivalents and restricted cash equivalents | ||
| Cash and cash equivalents | ||
| Restricted cash equivalents included in prepaid expenses and other current assets | ||
| Restricted cash equivalents included in other assets | ||
| Total cash, cash equivalents and restricted cash equivalents | ||
| Unpaid purchases of property, plant and equipment | $1,247 | $546 |
| Right-of-use asset and operating lease obligations from new lease | $105 | |
| Right-of-use assets derecognized in connection with lease termination | $13,362 |